Where Innovation Becomes Impact

Helping emerging biotech companies secure the partnerships, capital, and exits they deserve.

Buy-side expertise applied to sell-side biotech challenges. We help founders navigate complex deals with confidence.

Embedded CBO and business development leadership for emerging biotech companies that need strategic firepower without full-time overhead. We integrate with your team to drive strategic planning, build BD infrastructure, represent the company at the board level, and support investor communications. Full engagement, flexible structure.

Fractional Executive Leadership

End-to-end partnership strategy from initial target identification through signed agreements. We identify and qualify the right partners, develop deal positioning, structure term sheets that protect your interests, lead negotiations, and manage alliances post-close. Every step handled with the rigor of someone who has been on the other side of the table.

Strategic Partnerships & Licensing

Comprehensive sell-side advisory for biotech companies pursuing strategic exits. We develop valuation frameworks, position your company's story for acquirers, identify and engage potential buyers, prepare data rooms and management presentations, and guide you through due diligence and transaction execution. Built to maximize outcomes, not just close deals.

M&A Advisory

Capital strategy and execution from seed through growth stages. We identify the right investor targets, develop compelling pitch materials and data rooms, manage due diligence processes, and negotiate term sheets that align with your goals. Whether you need strategic introductions, investor preparation, or hands-on support through close, we tailor the engagement to match the complexity of your raise.

Fundraising Strategy

Track Record of Success

Proven results across two decades of life sciences deal-making, from global pharmaceutical leadership to hands-on advisory for emerging biotech companies.

$16B+

Strategic Transactions

$200M+

Capital Secured

$635M+

Portfolio Exits

Current Portfolio

Expertise

Deal expertise without scientific context leads to generic advice. Scientific depth without deal experience leads to missed opportunities. We operate at the intersection, bringing hands-on experience across therapeutic areas, platform technologies, and transaction types to help biotech companies navigate complex partnering environments.

Our work spans the full transaction lifecycle: fundraising strategy, strategic partnerships, in-licensing and out-licensing, research collaborations, and M&A. Whether you're raising your first institutional round or preparing for an exit, we structure our engagements around what your company needs right now.

The right guidance at the right moment changes the trajectory of a company.

Insights

About

Tim Foley, Founder & Managing Director

Most of my career was spent inside Takeda and Astellas, leading business development teams that evaluated thousands of opportunities across assets, platforms, and technologies. That experience taught me how global pharmaceutical organizations source, evaluate, and structure deals. I saw firsthand why some companies got partnerships while others with equally strong science did not.

Scout Life Sciences exists to bring that perspective to the founders who need it most. Today, I work hands-on with biotech leadership teams as a fractional executive and strategic advisor, helping navigate the fundraising, partnerships, and exits that will shape your company's future. I know what pharma is looking for because I used to be the one looking.